Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
05/2004
05/26/2004CN1499972A Imidazolyl derivatives as corticotropin releasing factor inhibitors
05/26/2004CN1499969A pharmaceutical formulation contg. pyrazolo[4,3-D] pyrimidine and nitrates or thienopyrimidines and nitrates
05/26/2004CN1499968A Method of treatment of dopamine-related dysfuction
05/26/2004CN1498650A Granule for artesian spring of stimulate milk secretion and preparing technique
05/26/2004CN1498643A Method for preparing Chinese medica preparation for treating gynecopathy
05/26/2004CN1151167C Purine derivatives
05/26/2004CN1151155C 1,5-dihydro-pyrazolo [3,4-D]-pyrimidinone derivatives
05/26/2004CN1151152C New polycyclicazindole compound, its preparation method are medicine composition containing same
05/26/2004CN1150938C Capsule for treating gynaecologic inflammation, and its prepn. process
05/26/2004CN1150920C Medicine for treating female dimacteric syndrome and its preparing process
05/26/2004CN1150904C Pharmaceutical compositions for oral administration of molecular iodine
05/25/2004US6740777 Mercaptoalkyl benzoic acid derivative are useful for inhibiting naaladase (acetylated alpha-linked acidic dipeptidase/n-/) enzyme activity
05/25/2004US6740660 For amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to mammal
05/25/2004US6740656 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
05/25/2004US6740645 17β-acyl-17α-propynyl-11β-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties
05/25/2004US6740327 Use for cosmetic and dermatological indications, reducing and soothing mucosa and skin erythema, inflammation or reaction caused by internal or external factors, wound healing, etc.
05/25/2004US6740309 Delivery of compounds for the treatment of migraine through an inhalation route
05/25/2004US6740308 Composition comprising condensation aerosol formed by volatilizing antihistamine under conditions effective to produce heated vapor and condensing to form condensation aerosol particles having less than 5% degradation products
05/25/2004US6740307 Delivery of β-blockers through an inhalation route
05/25/2004US6740306 Imidazotriazinone-containing compositions for nasal administration
05/25/2004CA2115170C Imidazolyl-alkenoic acids
05/25/2004CA2101871C Transdermic pharmaceutical preparation
05/21/2004WO2004042077A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b)
05/21/2004WO2004041289A1 Cardiovascular protection using anti-aldosteronic progestins
05/21/2004WO2004041288A1 Hormone replacement therapy with drospirenone
05/21/2004WO2004041282A1 Receptor regulator
05/21/2004WO2004041266A1 Receptor function controlling agent
05/21/2004WO2004041259A1 Treatment of female sexual dysfunction
05/21/2004WO2004011029A3 Pharmaceutical compositions for penis enlargement
05/21/2004WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists
05/21/2004WO2003088900A3 Solid forms of salts with tyrosine kinase activity
05/21/2004WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
05/21/2004WO2003020240A3 Therapeutic agent delivery tampon
05/21/2004WO2002067952A8 Prophylactic teat treatment
05/21/2004CA2505322A1 Receptor function regulator
05/21/2004CA2504805A1 Receptor regulator
05/20/2004US20040097597 Reducing side effects while elevating serum testosterone levels; having higher trans to cis ratio
05/20/2004US20040097591 Increasing testosterone levels; sexual dysfunction; kits
05/20/2004US20040097551 As inhibitors of glucosylceramide synthase; for therapy and prophylaxis
05/20/2004US20040097546 For therapy of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction
05/20/2004US20040097505 Reacting benzamide derivative with haloketone compound to form imidazotriazine compound
05/20/2004US20040097498 For prophylaxis and/or therapy of disorders of the urogenital system such as hypetrophy of the prostate, incontinence and in particular erectile dysfunction and female sexual dysfunction, cerebrovascular disorders
05/20/2004US20040097495 Method for treating fibrotic diseases or other indications IIIC
05/20/2004US20040097477 For controlling male fertility in a mammal
05/20/2004US20040097425 Peptide compounds
05/20/2004US20040097407 Method for the synthesis of compounds of formula I and their uses thereof
05/20/2004US20040096881 For prophylactics/diagnostics/therapeutics; endothelial nitric oxide synthase (eNOS)
05/19/2004EP1420020A1 4-oxoimidazolidine-2-spiropiperidine derivative
05/19/2004EP1419776A2 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/19/2004EP1419773A2 4-Phenylpiperidine derivatives as modulators of dopamine neurotransmission
05/19/2004EP1419394A2 Modulation of steroid hormone uptake
05/19/2004EP1419256A2 Conjugates for the modulation of immune responses
05/19/2004EP1419239A1 Mullerian inhibiting substance levels and ovarian response
05/19/2004EP1419178A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
05/19/2004EP1419158A1 Pteridinone derivatives as modulators of chemokine receptor activity
05/19/2004EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
05/19/2004EP1419143A1 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3
05/19/2004EP1418931A1 New drug
05/19/2004EP1418921A1 Anti-tumour 2-alkoxyestradiol sulfamates
05/19/2004EP1418920A1 As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness
05/19/2004EP1418907A1 Novel alpha adrenergic agents
05/19/2004EP1418902A1 Novel methods and compositions for the treatment or prevention of dysmenorrhoea and menstrual side effects: the use of phospholipase inhibitors
05/19/2004EP1418900A1 Selective estrogen receptor modulators
05/19/2004EP1418896A2 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
05/19/2004EP1418895A1 Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups
05/19/2004EP1259505B1 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
05/19/2004EP1220855B1 Anhydrous salt
05/19/2004EP1204416A4 Carnitine analogues as topical, microbicidal spermicides
05/19/2004EP1128811B1 Drug delivery device, especially for the delivery of progestins and estrogens
05/19/2004EP0984965B1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
05/19/2004DE60100389T2 Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung Fat-soluble substances containing granules, and processes for their preparation
05/19/2004DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions
05/19/2004DE10251028A1 Verwendung von Progesteron oder einem Progesteronrezeptor-Agonisten zur Hemmung der Steroidsynthese Use of progesterone or a progesterone receptor agonists for the inhibition of steroid synthesis
05/19/2004CN1498217A Heterocyclic compounds for aging-related and diabetic vascular complications
05/19/2004CN1498096A Condom with erectogenic composition
05/19/2004CN1150187C Use of selective antagonists of a1b-adrenergic receptor for improvement of sexual dysfunction
05/19/2004CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors
05/19/2004CN1150175C Derivatives of 1,3,4-oxadiazolone
05/19/2004CN1150023C Medicine for curing male infertility and female sterility
05/19/2004CN1150009C Traditional Chinese medicine for female acyesis
05/19/2004CN1149971C Cosmetic or pharmaceutical compositions consisting of liposomes, its preparation method and use
05/18/2004US6737507 Antiangiogenic peptides and compositions thereof
05/18/2004US6737084 Borage seed oil, angelica pubescens root, coleus forskohlii extract, vinpocetine, ferulic acid, magnesium, ascorbyl palmitate, capric/caprylic triglyceride, and silica; topical
05/18/2004US6737068 Wipe formulation
05/18/2004US6737042 Delivery of drug esters through an inhalation route
05/13/2004WO2004039794A1 Cell activator, process for producing cell activator and appratus therefor
05/13/2004WO2004039396A1 Drug containing angiotensin convertase
05/13/2004WO2004014271A9 Protection of the female reproductive system from natural and artificial insults
05/13/2004WO2003080022A3 Analgesics for nasal administration
05/13/2004WO2003066859A3 Amino acid sequences capable of facilitating penetration across a biological barrier
05/13/2004WO2002056903A9 Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
05/13/2004WO2002055013A8 Therapeutic chromone compounds
05/13/2004US20040092744 Process for preparing crystalline form I of cabergoline
05/13/2004US20040092742 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists
05/13/2004US20040092578 Inhibition of the cystic fibrosis transmembrane conductance regulator chloride channel
05/13/2004US20040092545 Sulfonamido ether substituted imidazoquinolines
05/13/2004US20040092533 Central nervous system disorders; anxiolytic agents; anticonvulsants; cognition activators; side effect reduction
05/13/2004US20040092525 Pirazino(aza)indole derivatives
05/13/2004US20040092519 New treatment for hot flashes
05/13/2004US20040092515 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors